Literature DB >> 15270852

Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

H Cullup1, P G Middleton, G Duggan, J S Conn, A M Dickinson.   

Abstract

Cytokine production may be regulated by both genotypic (single nucleotide or tandem repeat polymorphisms) and non-genotypic factors relating to the environment and inherent biology (i.e. gender). Interleukin (IL)-1 is one of the body's most highly proinflammatory cytokines and is implicated in the pathophysiology of numerous diseases, but also in the maintenance of homeostasis in a number of tissues. The cytokine IL-1 receptor antagonist (IL-1Ra) is the competitive inhibitor of the IL-1 agonists IL-1alpha and IL-1beta. In vivo IL-1Ra was measured in a cohort of 200 + blood donors and the effect of the IL-1 gene polymorphisms, environmental and biological factors assessed. In this study, we observed that possession of particular alleles of 5 IL-1 gene polymorphisms (IL1A-889, IL1Alpha VNTR, IL1B -511, IL1B +3953 and the IL1RN VNTR) did not correlate with higher plasma IL-1Ra levels. Environmental factors such as smoking and non-steroidal anti-inflammatory drug ingestion were associated with higher in vivo IL-1Ra levels (P = 0.015 and 0.022, respectively), but biological factors such as gender, age and menstruation status did not have any impact upon in vivo IL-1Ra levels. Genotypic associations of IL-1 gene family polymorphisms with disease features may reflect characteristics of stressed rather than normal control circuits for cytokine production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270852      PMCID: PMC1809100          DOI: 10.1111/j.1365-2249.2004.02531.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  55 in total

Review 1.  Polymorphisms related to inflammation in the interleukin-1 system genes: a step forward in the search for predisposing conditions to ischemic heart disease.

Authors:  R De Caterina
Journal:  Cardiologia       Date:  1999-09

Review 2.  Interleukin-1 family: from genes to human disease.

Authors:  B Laurincová
Journal:  Acta Univ Palacki Olomuc Fac Med       Date:  2000

3.  Interleukin-1 haplotype and periodontal disease progression following therapy.

Authors:  B Ehmke; W Kress; H Karch; T Grimm; B Klaiber; T F Flemmig
Journal:  J Clin Periodontol       Date:  1999-12       Impact factor: 8.728

4.  Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender.

Authors:  J M Daun; R W Ball; J G Cannon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-04       Impact factor: 3.619

5.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

6.  Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis.

Authors:  X M Fang; S Schröder; A Hoeft; F Stüber
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

7.  Smoking and GCF levels of IL-1beta and IL-1ra in periodontal disease.

Authors:  L Boström; L E Linder; J Bergström
Journal:  J Clin Periodontol       Date:  2000-04       Impact factor: 8.728

8.  Association of interleukin-1 gene polymorphisms with early-onset periodontitis.

Authors:  J M Parkhill; B J Hennig; I L Chapple; P A Heasman; J J Taylor
Journal:  J Clin Periodontol       Date:  2000-09       Impact factor: 8.728

9.  Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.

Authors:  B L Langdahl; E Løkke; M Carstens; L L Stenkjaer; E F Eriksen
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

10.  IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes.

Authors:  M Hurme; S Santtila
Journal:  Eur J Immunol       Date:  1998-08       Impact factor: 5.532

View more
  4 in total

1.  Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

Authors:  Anne E Sanders; William Maixner; Andrea G Nackley; Luda Diatchenko; Kunthel By; Vanessa E Miller; Gary D Slade
Journal:  J Pain       Date:  2011-10-26       Impact factor: 5.820

Review 2.  The microbiome, parturition, and timing of birth: more questions than answers.

Authors:  Amanda L Prince; Kathleen M Antony; Derrick M Chu; Kjersti M Aagaard
Journal:  J Reprod Immunol       Date:  2014-04-18       Impact factor: 4.054

3.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

4.  Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children.

Authors:  Satu Seppä; Sirpa Tenhola; Raimo Voutilainen
Journal:  J Endocr Soc       Date:  2018-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.